The supernatants of dual-agent-treated HCC cells inhibited ERK phosphorylation and Fibronectin and α-SMA expression in HSCs, while rSDF-1α reversed these inhibitory effects (Figure 6F). This evidence concerns the gene ACTA1 and hepatocellular carcinoma.